Vimarsana
Biggest News Aggregation in the World

Page 4 - Action Indicated News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Action Indicated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Action Indicated Today - Breaking & Trending Today

Bliss GVS Pharma Ltd updates on inspection by USFDA - Vimarsana News

Bliss GVS Pharma Ltd updates on inspection by USFDA

Bliss GVS Pharma Ltd has now received the EIR indicating closure of the inspection through which the US FDA agency assigned the inspection classification of the facility as Voluntary Action Indicated.

Jubilant Pharmova arm gets OAI status from USFDA for Montreal facility - Vimarsana News

Jubilant Pharmova arm gets OAI status from USFDA for Montreal facility

The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.

Sun Pharma shares slip 3% intraday as shipments from Mohali facility temporarily suspended - Vimarsana News

Sun Pharma shares slip 3% intraday as shipments from Mohali facility temporarily suspended

Sun Pharma stock has gained 5.88 per cent in a year and fallen 2.29 percent in 2023. A total of 0.52 lakh shares of the firm changed hands amounting to a turnover of Rs 5.08 crore on BSE.

Sun Pharma temporarily halts shipments from Mohali facility to implement US FDA-mandated measures - Vimarsana News

Sun Pharma temporarily halts shipments from Mohali facility to implement US FDA-mandated measures

"US FDA has directed the Company to take certain corrective actions at the Mohali facility before releasing further final product batches into the US," the company said.

USFDA assigns VAI classification to Jubilant Pharmova's API facility at Nanjangud - Vimarsana News

USFDA assigns VAI classification to Jubilant Pharmova's API facility at Nanjangud

The USFDA has assigned the inspection classification of the API facility as 'Voluntary Action Indicated' pursuant to its inspection at the API manufacturing facility of Jubilant Pharmova Ltd at Nanjangud during 05-13 December 2022.